Medium-Term Follow-Up of Alpha-D Cervical Disk Prosthesis

Ataturk University

Status: Completed

Conditions: Cervical Disc Disease

Treatments: Device: Alpha-D CDP

Study type: Observational

Funder types: Other

Identifiers

NCT05262478

ATANEUROSURGERY-2

Details and patient eligibility

About

Prostheses use subsequently became prevalent and a number of studies were conducted. However, prosthesis-associated heterotropic ossification (HO) in the segments with prostheses was reported in 2005, which disrupted mobility and caused fusion.

In the present study, we aimed to investigate the clinical outcomes, HO incidence, and prosthesis mobility in the patients following the operative use of Alpha-D disc prosthesis as developed and used by the authors to treat cervical disk diseases.

Enrollment: 33 patients

Sex: All

Ages: 27 to 59 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• cervical disc hernia
• underwent cervical discectomy and received cervical disc prostheses

Exclusion criteria

• history of cervical surgery,
• kyphotic deformity,
• rheumatological or other systemic diseases,
• severe osteophytes caused by advanced degenerative disc disease
• severe spinal stenosis

Trial design

33 participants in 1 patient group

Alpha-D cervical disc prosthesis

Description:

Alpha-D cervical disc prosthesis was developed jointly by the Spine Center of Koç University Faculty of Medicine and Toledo University Bioengineering Department. It was designed as a single unit to ensure user-friendly administration for surgeons, and it was designed and manufactured to reproduce the movements of the normal cervical movement segment.

Treatment:

Device: Alpha-D CDP